Abstract: Human antibodies, preferably recombinant human antibodies that specifically bind to human Fas Ligand (hFasL) are disclosed. These antibodies have high affinity for hFasL, a slow off rate for hFasL dissociation and neutralize a Fas Ligand activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antigen-binding portions, of the invention are useful for neutralizing Fas Ligand activity, e.g., in a human subject suffering from a disorder in which hFas Ligand activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant anti-hFasL human antibodies, and the methods for synthesizing the recombinant human antibodies are also encompassed by the invention.

Abstract: An injection molded commercial pool pump is provided having a motor, an adapter plate connected to the motor, a housing connected to the adapter plate further comprising a channel, a sealing plate positioned between the adapter plate and housing, an impeller connected to the motor shaft, an o-ring positioned between the sealing plate and housing to prevent leaking of internal fluids and a diffuser positioned over the impeller and connected to the sealing plate where the diffuser and impeller are inserted into the channel.

Abstract: Isolated nucleic acid molecules encoding polypeptides from a human, reagents related thereto (including purified polypeptidesspecific antibodies) are provided. Methods of using said reagentsand diagnostic kits are also provided.